The assumption of ADORA3 overexpression in liver tumors has been based on observations in other tumors, single cases of mRNA expression in HCC tissues, or ADORA3 levels in peripheral blood mononuclear cells, which were postulated to be a surrogate marker for tumor expression.8 Here, ADORA3 is linked to hepatocellular carcinoma.